文献速递创面修复显微修复重建颅颌面外科

可吸收3D打印支架的再生匹配轴向血管化用于大段骨缺损:首次人体系列

Regenerative matching axial vascularisation of absorbable 3D-printed scaffold for large bone defects: A first in human series.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2022-03-09

本文报告基于再生匹配轴向血管化(RMAV)的新型骨替代技术的首次临床系列,共4例:骨髓炎治疗后胫骨缺损、创伤及钛颅骨修补失败后颅盖缺损、新辅助化疗及尤文肉瘤切除后儿童胫骨缺损、先天性半侧颜面短小所致儿童下颌骨缺损。所有患者均以三维(3D)打印医用级聚己内酯与磷酸三钙(mPCL-TCP)支架包裹血管化游离皮质骨膜瓣重建;随访中等时长后全部形成功能性负重再生骨,其中病例1的36 cm为迄今成功重建的最长负重骨段。作者认为该技术可能为既往认为不可重建的骨缺损提供重建机会,但这些潜在获益尚需在前瞻性临床试验中正式检验。

要点

  • 4例均以3D打印mPCL-TCP支架包裹血管化游离皮质骨膜瓣完成重建,随访中等时长后全部形成功能性负重再生骨。
  • 病例1重建长度36 cm,为迄今成功重建的最长负重骨段。
  • 作者认为该技术可能安全、可靠、结局可预测,但潜在获益尚需前瞻性临床试验正式检验。

核心结论

  • 作者认为该技术可能为既往认为不可重建的骨缺损提供重建机会,降低长期植入物相关并发症风险,并在恶劣环境中取得这些结局。
  • 作者指出这些潜在获益尚需在前瞻性临床试验中正式检验。

研究设计与样本

  • 首次人体系列,共4例:骨髓炎治疗后胫骨缺损、创伤及钛颅骨修补失败后颅盖缺损、新辅助化疗及尤文肉瘤切除后儿童胫骨缺损、先天性半侧颜面短小所致儿童下颌骨缺损。
  • 所有患者均以3D打印医用级聚己内酯与磷酸三钙(mPCL-TCP)支架包裹血管化游离皮质骨膜瓣重建。

主要发现

  • 随访中等时长后,全部病例均形成功能性负重再生骨。
  • 病例1重建长度为36 cm,为迄今成功重建的最长负重骨段。

临床怎么用

  • 作者认为该技术可作为现有大段骨缺损重建方法的替代选择,可能在具有挑战性的情况下安全、可靠并给出可预测的结局。
  • 作者认为该技术可能有助于重建既往认为不可重建的骨缺损,并降低长期植入物相关并发症风险。

局限性

  • 原文结论指出这些潜在获益尚需在前瞻性临床试验中正式检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We describe the first clinical series of a novel bone replacement technique based on regenerative matching axial vascularisation (RMAV). This was used in four cases: a tibial defect after treatment of osteomyelitis; a calvarial defect after trauma and failed titanium cranioplasty; a paediatric tibial defect after neoadjuvant chemotherapy and resection of Ewing sarcoma; and a paediatric mandibular deficiency resulting from congenital hemifacial microsomia. METHOD: All patients underwent reconstruction with three-dimensional (3D)-printed medical-grade polycaprolactone and tricalcium phosphate (mPCL-TCP) scaffolds wrapped in vascularised free corticoperiosteal flaps. OUTCOME: Functional volumes of load-sharing regenerate bone have formed in all cases after a moderate duration of follow-up. At 36 cm, case 1 remains the longest segment of load bearing bone ever successfully reconstructed. This technique offers an alternative to existing methods of large volume bone defect reconstruction that may be safe, reliable, and give predictable outcomes in challenging situations. It achieves this by using a bioresorbable scaffold to support and direct the growth of regenerate bone, driven by RMAV. CONCLUSION: This technique may facilitate the reconstruction of bone defects previously thought unreconstructable, reduce the risk of long-term implant-related complications and achieve these outcomes in a hostile environment. These potential benefits must now be formally tested in prospective clinical trials.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Castrisos G, Gonzalez Matheus I, Sparks D, et al. Regenerative matching axial vascularisation of absorbable 3D-printed scaffold for large bone defects: A first in human series. J Plast Reconstr Aesthet Surg. 2022. PMID: 35370116. doi:10.1016/j.bjps.2022.02.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。